Global Bioresorbable Polymers Market Size, Share & Trends Analysis Report by Product (Polysaccharides, Proteins, Polylactic Acid, Polyglycolic Acid, Polycaprolactone, Others), by Application (Drug Delivery, Orthopedics, Others), and by Region (North America, Europe, Asia Pacific, Latin America, Middle East) - Size, Share, Outlook, and Opportunity Analysis, 2023 ? 2030.

Report ID : AMR1004306 | Industries : Others | Published On :December 2023 | Page Count : 244

Global Bioresorbable Polymers Market Size, Share & Trends Analysis Report by Product (Polysaccharides, Proteins, Polylactic Acid, Polyglycolic Acid, Polycaprolactone, Others), by Application (Drug Delivery, Orthopedics, Others), and by Region (North America, Europe, Asia Pacific, Latin America, Middle East) - Size, Share, Outlook, and Opportunity Analysis, 2023 – 2030.

Global Bioresorbable Polymers Market

Global Bioresorbable Polymers Market was valued at USD 475 million in 2022 which expected to reach USD 789 million by 2030, at a CAGR 6.4% from 2023-2030.
Bioresorbable polymers are biodegradable materials that break down in the body over time, eliminating the need for surgical removal. They are often used in medical devices and implants, such as sutures and drug delivery systems.

Market Drivers

The main drivers of industrial growth are the rise in surgical operations, better healthcare facilities, and greater consumer health awareness on a global scale. Globally, there are over 310 million major procedures performed each year, according to data from the National Library of Medicine (NLM) in 2020. Of them, 20 million or more are done in Europe and 40–50 million in the United States. Bioresorbable or bioabsorbable polymers belong to a group of substances that the body can gradually break down and absorb.

Market Restraints

Degradation Rate Control: The rate of bioresorption must be precisely controlled to match the healing or drug release timeline. Balancing the degradation rate with the body's healing process or the drug's therapeutic window can be challenging.

Market Segmentation

The Global Bioresorbable Polymers Market is segmented into Product such as Polysaccharides, Proteins, Polylactic Acid, Polyglycolic Acid, Polycaprolactone, Others. Moreover, market is further segmented into Application such as Drug Delivery, Orthopedics, Others.

Regional Analysis

The Global Bioresorbable Polymers Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
North America among regions is expected to exhibit the highest CAGR in the global Bioresorbable Polymers market. This is explained by the rising product usage in orthopaedics and drug delivery applications in the area. The U.S. is the primary centre for research and development in the healthcare sector, which contributes to the market expansion in North America. Additionally, the region's need for bioresorbable polymers is supported by the growing demand for orthopaedics and drug delivery applications.
The demand for state-of-the-art surgical products, the expansion of private-sector hospitals into rural areas, the adoption of favourable government initiatives, the growing number of hospitals, high investments in the healthcare sector, and rising per capita income are all factors driving the growth of the APAC market.

Key Developments

In August 2021, Evonik Industries AG bought JeNaCell, a German biotech business, to expand its biomaterials product line in the healthcare industry. The acquisition will aid Evonik's Nutrition & Care division's portfolio change to system solutions and will increase the division's natural goods for the medical technology platform.

Key Players

Various key players are listed in the global Bioresorbable Polymers market including- Corbion NV, Evonik Industries AG, Poly-Med Inc., Foster Corp, Abbott, KLS Martin Group, 3D Biotek LLC, Sunstar Suisse S.A., Koninklijke DSM N.V., Futerro.

Market Taxonomy

By Product
• Polysaccharides
• Proteins
• Polylactic Acid
• Polyglycolic Acid
• Polycaprolactone
• Others
By Application
• Drug Delivery
• Orthopedics
• Others
By Region
• North America
o U.S.
o Canada
o Mexico
• Latin America
o Brazil
o Argentina
o Colombia
o Peru
o Chile
o Venezuela
o Rest of Latin America
• Europe
o Germany
o France
o UK
o Russia
o Italy
o Spain
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o South Korea
o Australia
o New Zealand
o Singapore
o Malaysia
o Rest of Asia Pacific
• Middle East & Africa
o Saudi Arabia
o UAE
o Egypt
o Kuwait
o South Africa
o Rest Middle East & Africa

Key Questions Addressed by the Report

• What are the Key Opportunities in Global Bioresorbable Polymers Market?
• What will be the growth rate from 2023 to 2030?
• Which segment/region will have highest growth?
• What are the factors that will impact/drive the Market?
• What is the competitive Landscape in the Industry?
• What is the role of key players in the value chain?
• What are the strategies adopted by key players?

Global Bioresorbable Polymers Market

1. Introduction
1.1. Objective of the Study
1.2. Market Definition
1.3. Market Scope
2. Research Methodology
2.1. Data Mining
2.2. Validation
2.3. Primary Interviews
2.4. List of Data Sources
3. Executive Summary
4. Global Bioresorbable Polymers Market Outlook
4.1. Overview
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Cumulative Impact due to recent Energy Crisis
4.2.5. Cumulative Impact due to Nearing Economic Downturn
4.2.6. Post Covid-19 World Supply and Demand Conditions
4.2.7. Cumulative Impact of Russia-Ukraine Conflict
4.3. Porters Five Force Model
4.4. Value Chain Analysis
5. Global Bioresorbable Polymers Market, By Product
5.1. Y-o-Y Growth Comparison, By Product
5.2. Global Bioresorbable Polymers Market Share Analysis, By Product
5.3. Global Bioresorbable Polymers Market Size and Forecast, By Product
5.3.1. Polysaccharides
5.3.2. Proteins
5.3.3. Polylactic Acid
5.3.4. Polyglycolic Acid
5.3.5. Polycaprolactone
5.3.6. Others
6. Global Bioresorbable Polymers Market, By Application
6.1. Y-o-Y Growth Comparison, By Application
6.2. Global Bioresorbable Polymers Market Share Analysis, By Application
6.3. Global Bioresorbable Polymers Market Size and Forecast, By Application
6.3.1. Drug Delivery
6.3.2. Orthopedics
6.3.3. Others
7. Global Bioresorbable Polymers Market, By Region
7.1. Global Bioresorbable Polymers Market Share Analysis, By Region
7.2. Global Bioresorbable Polymers Market Share Analysis, By Region
7.3. Global Bioresorbable Polymers Market Size and Forecast, By Region
8. North America Bioresorbable Polymers Market Analysis and Forecast (2023-2030)
8.1. Introduction
8.2. North America Bioresorbable Polymers Market Share Analysis, By Product
8.3. North America Bioresorbable Polymers Market Share Analysis, By Application
8.4. North America Bioresorbable Polymers Market Size and Forecast, By Country
8.4.1. U.S.
8.4.1.1. Market Size and Forecast, By Product
8.4.1.2. Market Size and Forecast, By Application
8.4.2. Canada
8.4.2.1. Market Size and Forecast, By Product
8.4.2.2. Market Size and Forecast, By Application
8.4.3. Mexico
8.4.3.1. Market Size and Forecast, By Product
8.4.3.2. Market Size and Forecast, By Application
9. Europe Bioresorbable Polymers Market Analysis and Forecast (2023-2030)
9.1. Introduction
9.2. Europe Bioresorbable Polymers Market Share Analysis, By Product
9.3. Europe Bioresorbable Polymers Market Share Analysis, By Application
9.4. Europe Bioresorbable Polymers Market Size and Forecast, By Country
9.4.1. Germany
9.4.1.1. Market Size and Forecast, By Product
9.4.1.2. Market Size and Forecast, By Application
9.4.2. France
9.4.2.1. Market Size and Forecast, By Product
9.4.2.2. Market Size and Forecast, By Application
9.4.3. UK
9.4.3.1. Market Size and Forecast, By Product
9.4.3.2. Market Size and Forecast, By Application
9.4.4. Russia
9.4.4.1. Market Size and Forecast, By Product
9.4.4.2. Market Size and Forecast, By Application
9.4.5. Italy
9.4.5.1. Market Size and Forecast, By Product
9.4.5.2. Market Size and Forecast, By Application
9.4.6. Spain
9.4.6.1. Market Size and Forecast, By Product
9.4.6.2. Market Size and Forecast, By Application
9.4.7. Rest of Europe
9.4.7.1. Market Size and Forecast, By Product
9.4.7.2. Market Size and Forecast, By Application
10. Asia Pacific Bioresorbable Polymers Market Analysis and Forecast (2023-2030)
10.1. Introduction
10.2. Asia Pacific Bioresorbable Polymers Market Share Analysis, By Product
10.3. Asia Pacific Bioresorbable Polymers Market Share Analysis, By Application
10.4. Asia Pacific Bioresorbable Polymers Market Size and Forecast, By Country
10.4.1. China
10.4.1.1. Market Size and Forecast, By Product
10.4.1.2. Market Size and Forecast, By Application
10.4.2. Japan
10.4.2.1. Market Size and Forecast, By Product
10.4.2.2. Market Size and Forecast, By Application
10.4.3. India
10.4.3.1. Market Size and Forecast, By Product
10.4.3.2. Market Size and Forecast, By Application
10.4.4. South Korea
10.4.4.1. Market Size and Forecast, By Product
10.4.4.2. Market Size and Forecast, By Application
10.4.5. Australia
10.4.5.1. Market Size and Forecast, By Product
10.4.5.2. Market Size and Forecast, By Application
10.4.6. New Zealand
10.4.6.1. Market Size and Forecast, By Product
10.4.6.2. Market Size and Forecast, By Application
10.4.7. Singapore
10.4.7.1. Market Size and Forecast, By Product
10.4.7.2. Market Size and Forecast, By Application
10.4.8. Malaysia
10.4.8.1. Market Size and Forecast, By Product
10.4.8.2. Market Size and Forecast, By Application
10.4.9. Rest of Asia
10.4.9.1. Market Size and Forecast, By Product
10.4.9.2. Market Size and Forecast, By Application
11. Latin America Bioresorbable Polymers Market Analysis and Forecast (2023-2030)
11.1. Introduction
11.2. Latin America Bioresorbable Polymers Market Share Analysis, By Product
11.3. Latin America Bioresorbable Polymers Market Share Analysis, By Application
11.4. Latin America Bioresorbable Polymers Market Size and Forecast, Country
11.4.1. Brazil
11.4.1.1. Market Size and Forecast, By Product
11.4.1.2. Market Size and Forecast, By Application
11.4.2. Argentina
11.4.2.1. Market Size and Forecast, By Product
11.4.2.2. Market Size and Forecast, By Application
11.4.3. Colombia
11.4.3.1. Market Size and Forecast, By Product
11.4.3.2. Market Size and Forecast, By Application
11.4.4. Peru
11.4.4.1. Market Size and Forecast, By Product
11.4.4.2. Market Size and Forecast, By Application
11.4.5. Chile
11.4.5.1. Market Size and Forecast, By Product
11.4.5.2. Market Size and Forecast, By Application
11.4.6. Venezuela
11.4.6.1. Market Size and Forecast, By Product
11.4.6.2. Market Size and Forecast, By Application
11.4.7. Rest of Latin America
11.4.7.1. Market Size and Forecast, By Product
11.4.7.2. Market Size and Forecast, By Application
12. Middle East Bioresorbable Polymers Market Analysis and Forecast (2023-2030)
12.1. Introduction
12.2. Middle East Bioresorbable Polymers Market Share Analysis, By Product
12.3. Middle East Bioresorbable Polymers Market Size and Forecast, By Application
12.4. Middle East Bioresorbable Polymers Market Size and Forecast, By Country
12.4.1. Saudi Arabia
12.4.1.1. Market Size and Forecast, By Product
12.4.1.2. Market Size and Forecast, By Application
12.4.2. UAE
12.4.2.1. Market Size and Forecast, By Product
12.4.2.2. Market Size and Forecast, By Application
12.4.3. Egypt
12.4.3.1. Market Size and Forecast, By Product
12.4.3.2. Market Size and Forecast, By Application
12.4.4. Kuwait
12.4.4.1. Market Size and Forecast, By Product
12.4.4.2. Market Size and Forecast, By Application
12.4.5. South Africa
12.4.5.1. Market Size and Forecast, By Product
12.4.5.2. Market Size and Forecast, By Application
12.4.6. Rest of Middle East & Africa
12.4.6.1. Market Size and Forecast, By Product
12.4.6.2. Market Size and Forecast, By Application
13. Competitive Analysis
13.1. Competition Dashboard
13.2. Market share Analysis of Top Vendors
13.3. Key Development Strategies
14. Company Profiles
14.1. Corbion NV.
14.1.1. Overview
14.1.2. Offerings
14.1.3. Key Financials
14.1.4. Business Segment & Geographic Overview
14.1.5. Key Market Developments
14.1.6. Key Strategies
14.2. Evonik Industries AG.
14.2.1. Overview
14.2.2. Offerings
14.2.3. Key Financials
14.2.4. Business Segment & Geographic Overview
14.2.5. Key Market Developments
14.2.6. Key Strategies
14.3. Poly-Med Inc.
14.3.1. Overview
14.3.2. Offerings
14.3.3. Key Financials
14.3.4. Business Segment & Geographic Overview
14.3.5. Key Market Developments
14.3.6. Key Strategies
14.4. Foster Corp
14.4.1. Overview
14.4.2. Offerings
14.4.3. Key Financials
14.4.4. Business Segment & Geographic Overview
14.4.5. Key Market Developments
14.4.6. Key Strategies
14.5. Abbott.
14.5.1. Overview
14.5.2. Offerings
14.5.3. Key Financials
14.5.4. Business Segment & Geographic Overview
14.5.5. Key Market Developments
14.5.6. Key Strategies
14.6. KLS Martin Group
14.6.1. Overview
14.6.2. Offerings
14.6.3. Key Financials
14.6.4. Business Segment & Geographic Overview
14.6.5. Key Market Developments
14.6.6. Key Strategies
14.7. 3D Biotek LLC.
14.7.1. Overview
14.7.2. Offerings
14.7.3. Key Financials
14.7.4. Business Segment & Geographic Overview
14.7.5. Key Market Developments
14.7.6. Key Strategies
14.8. Sunstar Suisse S.A.
14.8.1. Overview
14.8.2. Offerings
14.8.3. Key Financials
14.8.4. Business Segment & Geographic Overview
14.8.5. Key Market Developments
14.8.6. Key Strategies
14.9. Koninklijke DSM N.V.
14.9.1. Overview
14.9.2. Offerings
14.9.3. Key Financials
14.9.4. Business Segment & Geographic Overview
14.9.5. Key Market Developments
14.9.6. Key Strategies
14.10. Futerro.
14.10.1. Overview
14.10.2. Offerings
14.10.3. Key Financials
14.10.4. Business Segment & Geographic Overview
14.10.5. Key Market Developments
14.10.6. Key Strategies